Literature DB >> 18812020

Formulation and evaluation of primaquine phosphate taste-masked rapidly disintegrating tablet.

Punit P Shah1, Rajashree C Mashru.   

Abstract

This work investigates the complete bitter-taste-masking of primaquine phosphate (PRM) using a solid dispersion with mono ammonium glycyrrhyzinate pentahydrate (GLY). This work also describes the preparation of rapidly disintegrating tablets (RDTs) of PRM by a direct compression method using superdisintegrant, croscarmellose sodium. A solid dispersion was prepared by the solvent evaporation method. Fourier transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC) were performed to identify the physicochemical interaction between drug and carrier, hence its effect on dissolution. In-vitro drug release studies were performed for RDTs at both pH 1.2 and 6.8. Bitterness score was evaluated using a human gustatory sensation test. FTIR spectroscopy and DSC showed no interaction of PRM in GLY solid dispersion. RDTs prepared from solid dispersion showed complete bitter-taste-masking of PRM. RDTs containing solid dispersion exhibited a better dissolution profile, at both pH 1.2 and 6.8, than pure PRM. Thus, the solid dispersion technique can be successfully used for complete bitter taste masking of PRM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18812020     DOI: 10.1211/jpp/60.10.0003

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  2 in total

1.  Salt Engineering of Aripiprazole with Polycarboxylic Acids to Improve Physicochemical Properties.

Authors:  Hamideh Afrooz; Eman M Mohamed; Sogra F Barakh Ali; Sathish Dharani; Mohammad T H Nutan; Mansoor A Khan; Ziyaur Rahman
Journal:  AAPS PharmSciTech       Date:  2021-01-06       Impact factor: 3.246

2.  Formulation and evaluation of a protein-loaded solid dispersions by non-destructive methods.

Authors:  Ziyaur Rahman; Ahmed S Zidan; Mansoor A Khan
Journal:  AAPS J       Date:  2010-02-03       Impact factor: 4.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.